Pancreatic Cancer Research

ResearcherUniversity Health NetworkActive in the last 2 years

Philippe Lucien Bedard

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6771-2999; OpenAlex author ID A5041145711. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2010: 1 trial · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer. Co-author DOI 10.1016/j.clcc.2024.05.002↗
  2. A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma. Last author DOI 10.21037/jgo-22-86↗

Trials 1

  1. Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors Principal investigator NCT01145456↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lillian Siu · 2 shared papers, 2022–2024 · strength 0.27
  2. María Vila-Casadesús · 1 shared paper, 2024 · strength 0.16
  3. Alberto Hernando‐Calvo · 1 shared paper, 2024 · strength 0.16
  4. Aaron Richard Hansen · 1 shared paper, 2024 · strength 0.16
  5. Benjamin Haibe‐Kains · 1 shared paper, 2024 · strength 0.16
  6. Ana P. Vivancos · 1 shared paper, 2024 · strength 0.16
  7. David William Hedley · 1 shared paper, 2022 · strength 0.12
  8. Sandra Elisabeth Fischer · 1 shared paper, 2022 · strength 0.12
  9. Rachel Anne Goodwin · 1 shared paper, 2022 · strength 0.12
  10. Neesha C. Dhani · 1 shared paper, 2022 · strength 0.12
  11. Jennifer Jane Knox · 1 shared paper, 2022 · strength 0.12
  12. Steve Gallinger · 1 shared paper, 2022 · strength 0.12
  13. Kyaw Lwin Aung · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.